LIVE UPDATES: Tracking the coronavirus in New Jersey njspotlight.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njspotlight.com Daily Mail and Mail on Sunday newspapers.
UMass Medical School in Worcester is enrolling teens in a Moderna vaccine trial set to begin in February
Updated Jan 27, 2021;
Moderna’s version of the COVID-19 vaccine has already been authorized for emergency use in individuals 18 and older. UMass Medical School in Worcester is taking steps for the vaccine to receive the same authorization for teens in the United States.
In early February, UMass Medical School will begin enrolling adolescents ages 12 to 17 in clinical trials to test Moderna’s COVID vaccine. It will represent the first tests conducted for a younger population.
Moderna expects to enroll 3,000 adolescents at up to 15 sites nationwide in the trial called TeenCove, UMass Medical School said.
UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens By Susan E.W. Spencer January 26, 2021
UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna. The vaccine has already been authorized for emergency use in adults 18 years or older by the U.S. Food and Drug Administration. This is the first it is being tested in a younger population.
Moderna expects to enroll 3,000 adolescents at up to 15 sites nationwide. Enrollment in the trial, called TeenCove, is expected to start at the Medical School in early February. Adolescents and their families can visit the TeenCOVEStudy.com website for more information and to indicate their interest in participating.
Service members who are preparing to deploy outside of the United States within three months are now eligible to receive their two doses of a vaccine for COVID-19 at Fort George G. Meade.
Service members who are preparing to deploy outside of the United States within three months are now eligible to receive their two doses of a vaccine for COVID-19 at Fort George G. Meade.